APPLICATION OF THE CONSTANT EXPOSURE TIME TECHNIQUE TO TRANSFORMATION EXPERIMENTS WITH FISSION NEUTRONS - FAILURE TO DEMONSTRATE DOSE-RATE DEPENDENCE

被引:7
作者
BALCERKUBICZEK, EK [1 ]
HARRISON, GH [1 ]
TORRES, BA [1 ]
MCCREADY, WA [1 ]
机构
[1] ARMED FORCES RADIOBIOL RES INST,BETHESDA,MD
关键词
D O I
10.1080/09553009414550651
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
A direct comparison of the effectiveness of fission neutrons at high (11.0-31.3 cGy/min) or several low dose-rates (0.14-3.2 cGy/min) was carried out under identical conditions. Monolayers of exponentially growing C3H/10T1/2 cells were exposed at 37 degrees C to reactor-produced neutrons (fluence-mean energy E(n) = 0.68 MeV, less than or equal to 5% gamma component, frequency mean linear energy y(F) = 21 keV/mu m, dose mean lineal energy y(D) = 42 keV/mu m in an 8-mu m spherical cavity). Survival or transformation induction were studied at five doses from 10.5 to 94 cGy. In low dose-rate irradiations, these doses were protracted over 0.5, 1, 3 or 4.5 h, resulting in 17 different dose-rates. Up to six experiments were performed at each of five exposure times. Concurrently with transformation we studied cell proliferation in control versus cells irradiated at 40 cGy (acute and a 4.5-h protraction) and found no evidence of a shift in the cell cycle distribution among these cells. At a given dose and dose-rate, the effect of dose protraction on survival or transformation was assessed by the dose-rate modifying factor (DRMF), defined as the low:high dose-rate effect ratio at the same dose. Survival or transformation induction curves were nearly linear with initial slopes, respectively, of about 6.5 x 10(-3) or 6.2 x 10(-6) cGy(-1). Consistent with dose-response curves, DRMFs were independent of the dose and dose-rate. The mean values of the DRMF with their uncertainties and 99% confidence intervals, based on measurements in individual doses and dose-rates for survival or transformation were, respectively: 1.01 +/- 0.03 (0.92, 1.09) or 0.98 +/- 0.04 (0.83, 1.08) indicating a similar precision in determining DRMF for survival or transformation, and no dose or dose-rate influence on these end points.
引用
收藏
页码:559 / 569
页数:11
相关论文
共 58 条
[52]  
VERBINSKI VV, 1981, AFRRI TRIGA5793F2 RE, V2
[53]  
VERBINSKI VV, 1981, AFRRI TRIGA5793F1 RE, V1
[55]  
ZEMAN GH, 1988, RADIAT PROT DOSIM, V23, P317
[56]  
1976, ICRU26 INT COMM RAD
[57]  
1980, 7 AM ASS PHYS MED AM
[58]  
1985, CANCER RES, V5, P2395